Movatterモバイル変換


[0]ホーム

URL:


Eurekaselect logo
Bentham Newsletternewsletter banner
Login
Login

Forgot Your Password? New around here? Sign up
Register Cart 0
Generic placeholder image

Current Gene Therapy

Editor-in-Chief

ISSN (Print): 1566-5232
ISSN (Online): 1875-5631

Editorial [Hot Topic: Chimeric Vectors (Guest Editor: Maurizio Scarpa)]

Author(s):Maurizio Scarpa

Volume 4, Issue 4, 2004

Page: [i - i]Pages: 1

DOI:10.2174/1566523043345968

TIMBC 2025

Current Gene Therapy

Title: Editorial [Hot Topic: Chimeric Vectors (Guest Editor: Maurizio Scarpa)]

Volume: 4Issue: 4

Author(s):Maurizio Scarpa

Affiliation:

    Export Options

    About this article

    Cite this article as:

    Scarpa Maurizio, Editorial [Hot Topic: Chimeric Vectors (Guest Editor: Maurizio Scarpa)], Current Gene Therapy 2004; 4 (4) .https://dx.doi.org/10.2174/1566523043345968

    DOI
    https://dx.doi.org/10.2174/1566523043345968
    Print ISSN
    1566-5232
    Publisher Name
    Bentham Science Publisher
    Online ISSN
    1875-5631

    Call for Papers in Thematic Issues

    27 December, 2025
    Advances in CAR-T Cell Therapy and CRISP combination

    CAR-T cell therapy is a groundbreaking immunotherapy that has transformed cancer treatment, particularly in hematological malignancies like leukemia and lymphoma. It involves engineering a patient’s own T cells to express chimeric antigen receptors (CARs) that target and destroy cancer cells. The therapy has demonstrated remarkable success, achieving durable remissions in ...read more


    Guest Editor(s):Dr. Álvaro López Zaplana
    31 December, 2025
    Melatonin Signaling in Health and Disease

    Melatonin regulates a multitude of physiological functions, including circadian rhythms, acting as a scavenger of free radicals, an anti-inflammatory agent, a modulator of mitochondrial homeostasis, an antioxidant, and an enhancer of nitric oxide bioavailability. AANAT is the rate-limiting enzyme responsible for converting serotonin to NAS, which is further converted to ...read more


    Guest Editor(s):Dr. Yen Sung Huang
    31 December, 2025
    Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers.

    Programmed cell death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more


    Guest Editor(s):Dr. Hao Chi
    31 December, 2025
    The now and future of gene transfer technologies

    Gene and cell therapies rely on a gene delivery system which is safe and effective. Both viral and non-viral vector systems are available with specific pros and cons. The choice of a vector system is largely dependent on the application which is a balance between target tissue/disease and safety, efficacy ...read more


    Guest Editor(s):Dr. Bijay Dhungel
    Related Journals

    Current Enzyme Inhibition

    Current Molecular Medicine

    Current Genomics

    Current Protein & Peptide Science

    Current Signal Transduction Therapy

    Protein & Peptide Letters

    Current Bioinformatics

    Recent Patents on Biotechnology

    Current Pharmacogenomics and Personalized Medicine

    MicroRNA

    Related Books

    Medicinal Plants of Pilibhit Tiger Reserve (PTR) India

    Plant-Microbe Interactions: A Comprehensive Review

    Glycosylation and Glycation in Health and Diseases

    Phytogenic and Phytochemical as Alternative Feed Additives for Animal Production

    Methods and Techniques in Nematology

    Mind Maps in Clinical Biochemistry

    A Treatise on Ecological Science

    From SARS-CoV to MARS-CoV

    Microbiology for ICAR NET: A Comprehensive Exam Preparation Guide

    Decolorization by Thanatephorus Cucumeris Dec 1

    Article Metrics
    16
    Wayfinder Image
    TIMBC 2025
    Related Articles
    © 2025 Bentham Science Publishers |Privacy Policy

    [8]ページ先頭

    ©2009-2025 Movatter.jp